Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism 5-HT2A receptor inverse agonists(Serotonin 2a (5-HT2a) receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Preclinical | SE | 01 Oct 2001 |